Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
698 studies found for:    "Venous Thrombosis"
Show Display Options
Rank Status Study
21 Recruiting Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
Conditions: Neoplasms;   Venous Thrombosis
Intervention: Drug: Apixaban
22 Terminated Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Condition: Deep Venous Thrombosis
Intervention:
23 Recruiting Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
Condition: Deep Venous Thrombosis
Intervention: Drug: Rivaroxaban
24 Recruiting Immature Plateletes in the Etiopathology of Deep Venous Thrombosis
Conditions: Immature Platelets;   Deep Venous Thrombosis
Intervention: Other: Blood samples
25 Terminated Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
Conditions: Neoplasms;   Deep Vein Thrombosis
Intervention: Drug: Dalteparin (Fragmin)
26 Terminated
Has Results
Study of Arixtra to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
Condition: Venous Thrombosis
Intervention: Drug: Fondaparinux sodium
27 Completed A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate;   Drug: enoxaparin/unfractionated heparin;   Drug: warfarin
28 Completed
Has Results
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
29 Completed
Has Results
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Placebo
30 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
31 Active, not recruiting Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
Conditions: Venous Thrombosis;   Pregnancy
Intervention: Other: antepartum and postpartum
32 Terminated EVENT: Hydrotherapy and Deep Venous Thrombosis
Conditions: Pain;   Deep Venous Thrombosis
Interventions: Drug: thermal cure;   Drug: late thermal cure
33 Unknown  Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
34 Not yet recruiting Tranexamic Acid and Blood Clots in Knee Surgery
Condition: Venous Thrombosis
Intervention: Drug: Tranexamic Acid
35 Completed Incidence of Superficial Vein Thrombosis
Condition: Superficial Vein Thrombosis
Intervention: Other: consultation with a vascular physician
36 Terminated Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)
Condition: DEEP VEIN THROMBOSIS
Intervention:
37 Completed Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis
Condition: Deep Vein Thrombosis
Intervention: Procedure: catheter-directed venous thrombolysis
38 Recruiting Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
Condition: Symptomatic Superficial Vein Thrombosis
Interventions: Drug: Rivaroxaban;   Drug: Placebo
39 Recruiting The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
Condition: Suspected Deep Vein Thrombosis
Intervention:
40 Not yet recruiting Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Conditions: Deep Vein Thrombosis;   Post-Thrombotic Syndrome;   Venous Thrombosis
Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA);   Drug: Standard Anticoagulation Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.